(2S)-2-Amino-4-pentenoic acid structure
|
Common Name | (2S)-2-Amino-4-pentenoic acid | ||
|---|---|---|---|---|
| CAS Number | 16338-48-0 | Molecular Weight | 115.131 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 222.7±23.0 °C at 760 mmHg | |
| Molecular Formula | C5H9NO2 | Melting Point | 283 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 88.5±22.6 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of (2S)-2-Amino-4-pentenoic acid(S)-2-Allylglycine is a peptide derivative. |
| Name | (S)-(-)-2-Amino-4-Pentenoic Acid |
|---|---|
| Synonym | More Synonyms |
| Description | (S)-2-Allylglycine is a peptide derivative. |
|---|---|
| Related Catalog |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 222.7±23.0 °C at 760 mmHg |
| Melting Point | 283 °C (dec.)(lit.) |
| Molecular Formula | C5H9NO2 |
| Molecular Weight | 115.131 |
| Flash Point | 88.5±22.6 °C |
| Exact Mass | 115.063332 |
| PSA | 63.32000 |
| LogP | -0.06 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.461 |
| Water Solubility | soluble |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2922499990 |
| Precursor 7 | |
|---|---|
| DownStream 6 | |
| HS Code | 2922499990 |
|---|---|
| Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
|
Effects of chronic inhibition of GABA synthesis on attention and impulse control.
Pharmacol. Biochem. Behav. 135 , 97-104, (2015) Cortical GABA regulates a number of cognitive functions including attention and working memory and is dysregulated in a number of psychiatric conditions. In schizophrenia for example, changes in GABA ... |
|
|
Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.
Br. J. Pharmacol. , doi:10.1111/bph.12699, (2014) Vasopressin V1B receptor antagonists may be effective for the treatment of depression and anxiety and the objective of this study was to characterize the pharmacological profiles of two newly synthesi... |
| (+)-Allylglycine |
| (R)-Allylglycine |
| (S)-(-)-alpha-Allylglycine |
| MFCD00002627 |
| (2S)-2-aminopent-4-enoic acid |
| N-prop-2-en-1-ylglycine |
| Glycine, N-2-propen-1-yl- |
| (S)-2-Aminopent-4-enoic acid |
| N-Prop-2-en-1-ylglycin |
| (2S)-2-Amino-4-pentenoic acid |
| L-Allylglycine |
| DL-Allylglycine |
| (S)-(−)-2-Amino-4-pentenoic acid,L-2-Amino-4-pentenoic acid |
| N-Allylglycine |
| (Allylamino)acetic acid |
| (S)-2-amino-pent-4-enoic acid |
| L-α-allylglycine |
| (S)-(-)-2-Amino-4-pentenoic acid |
| (-)-Allylglycine |
| allylglycine |